SCHEMBL20907905

SCHEMBL20907905

O=C1CCN(c2ccc(N3CCS(=O)(=O)CC3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 4/20 0.51
FAAH O00519 5/20 0.39
KDM5B Q9UGL1 1/20 0.39
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
TGFBR1 P36897 1/20 0.37
ACVR1 Q04771 1/20 0.37
CDK1 P06493 1/20 0.37
CDK2 P24941 1/20 0.37
RORC P51449 1/20 0.36
LMNA P02545 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CCR6 P51684 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ABHD6 Q9BV23 1/20 0.36
PTGS2 P35354 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175496 0.78 KDM4E (0.59) KDM4EALDH1A1FAAHTGFBR1ACVR1
SCHEMBL12551119 0.78 KDM4E (0.59) KDM4EALDH1A1FAAHLMNATDP1
SCHEMBL10001302 0.78 KDM4E (0.59) KDM4EALDH1A1TGFBR1ACVR1LMNA
SCHEMBL12551114 0.78 KDM4E (0.59) KDM4EALDH1A1LMNAMAPTKMT2A
SCHEMBL5886084 0.78 KDM4E (0.65) KDM4EALDH1A1FAAHCDK1CDK2
SCHEMBL1235260 0.78 KDM4E (0.59) KDM4EALDH1A1FAAHTGFBR1ACVR1
SCHEMBL4563378 0.78 KDM4E (0.59) KDM4EALDH1A1FAAHKDM5BPRMT5
SCHEMBL18945542 0.78 KDM4E (0.59) KDM4EALDH1A1FAAHKDM5BPRMT5
SCHEMBL23701480 0.77 HSP90AA1 (0.65) KDM4EALDH1A1FAAHLMNAHSP90AA1
SCHEMBL10022346 0.77 KDM4E (0.54) KDM4EALDH1A1KDM5BRORCLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019073251-A1 LYSYL OXIDASE INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2019-04-18 WO disclosed